Cytomedix Reports Third Quarter Financial Results
14 nov. 2011 16h05 HE
|
Cytomedix, Inc.
GAITHERSBURG, Md., Nov. 14, 2011 (GLOBE NEWSWIRE) -- Cytomedix, Inc. (OTCBB:CMXI) (the "Company"), a leading developer of biologically active regenerative therapies for wound care, inflammation and...
CMS Approves Reconsideration Request for Reimbursement of Autologous PRP Gel in Chronic Wound Care
11 nov. 2011 08h00 HE
|
Cytomedix, Inc.
GAITHERSBURG, Md., Nov. 11, 2011 (GLOBE NEWSWIRE) -- Cytomedix, Inc. (OTCBB:CMXI) (the "Company"), a leading developer of biologically active regenerative therapies for wound care, inflammation and...
Cytomedix to Host Third Quarter 2011 Financial Results Conference Call on Tuesday, November 15, 2011
08 nov. 2011 08h30 HE
|
Cytomedix, Inc.
GAITHERSBURG, Md., Nov. 8, 2011 (GLOBE NEWSWIRE) -- Cytomedix, Inc. (OTCBB:CMXI), a leading developer of biologically active regenerative therapies for wound care, inflammation and angiogenesis, today...
Cytomedix Announces Option Agreement With Global Pharmaceutical Company for Distribution of AutoLogel System in Chronic Wound Market
14 oct. 2011 08h00 HE
|
Cytomedix, Inc.
GAITHERSBURG, Md., Oct. 14, 2011 (GLOBE NEWSWIRE) -- Cytomedix, Inc. (OTCBB:CMXI) (the "Company"), a leading developer of biologically active regenerative therapies for wound care, inflammation and...
Cytomedix Announces Multiple Presentations at the Symposium on Advanced Wound Care Fall 2011
11 oct. 2011 08h00 HE
|
Cytomedix, Inc.
GAITHERSBURG, Md., Oct. 11, 2011 (GLOBE NEWSWIRE) -- Cytomedix, Inc. (OTCBB:CMXI) (the "Company"), a leading developer of biologically active regenerative therapies for wound care, inflammation and...
Cytomedix Announces Publication in ePlasty of Systematic Review and Meta-Analysis on Use of Platelet Rich Plasma Gel in Wound Healing
22 sept. 2011 08h00 HE
|
Cytomedix, Inc.
GAITHERSBURG, Md., Sept. 22, 2011 (GLOBE NEWSWIRE) -- Cytomedix, Inc. (OTCBB:CMXI) (the "Company"), a leading developer of biologically active regenerative therapies for wound care, inflammation and...
Cytomedix Announces Publication of Data From Wound Outcomes Registry in the International Wound Journal
21 sept. 2011 08h00 HE
|
Cytomedix, Inc.
GAITHERSBURG, Md., Sept. 21, 2011 (GLOBE NEWSWIRE) -- Cytomedix, Inc. (OTCBB:CMXI) (the "Company"), a leading developer of biologically active regenerative therapies for wound care, inflammation and...
Cytomedix Launches PRP Hair Restoration Wound Care Program at the International Society of Hair Restoration Surgeons Annual Meeting
15 sept. 2011 08h30 HE
|
Cytomedix, Inc.
GAITHERSBURG, Md., Sept. 15, 2011 (GLOBE NEWSWIRE) -- Cytomedix, Inc. (OTCBB:CMXI) (the "Company"), a leading developer of biologically active regenerative therapies for wound care, inflammation and...
Cytomedix to Present at Rodman & Renshaw 13th Annual Global Investment Conference
08 sept. 2011 08h00 HE
|
Cytomedix, Inc.
ROCKVILLE, Md., Sept. 8, 2011 (GLOBE NEWSWIRE) -- Cytomedix, Inc. (OTCBB:CMXI) (the "Company"), a leading developer of biologically active regenerative therapies for wound care, inflammation and...
Cytomedix Announces Poster Presentations at the 26th Annual Clinical Symposium on Advances in Skin and Wound Care
07 sept. 2011 08h00 HE
|
Cytomedix, Inc.
GAITHERSBURG, Md., Sept. 7, 2011 (GLOBE NEWSWIRE) -- Cytomedix, Inc. (OTCBB:CMXI) (the "Company"), a leading developer of biologically active regenerative therapies for wound care, inflammation and...